Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease

Annals of Hematology

Volumn 88, Issue 5, 2009, Pages 479-483

  Ahmad, Firdos ^a   Kannan, Meganathan ^a   Biswas, Arijit ^a   Saxena, Renu ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

789Thr Ala amino acid polymorphism; Frequency; Genotype; Haplotype; Quantitative type VWD patients; VWF:Ag level

Indexed keywords

ALANINE; THREONINE; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING TIME; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HEMOSTASIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE; BLOOD CLOTTING TEST; CASE CONTROL STUDY; CLASSIFICATION; GENETICS; HOMOZYGOTE; NUCLEOTIDE SEQUENCE;

ALANINE; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; POLYMERASE CHAIN REACTION; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 63649119890     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0623-4     Document Type: Article

References (23)

1. Sadler JE, Mannucci PM, Berntorp E et al (2000) Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 84:160-174
2. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC (1993) Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr 123:893-898 doi: 10.1016/S0022-3476(05)80384-1
3. Ruggeri ZM (2003) Von Willebrand factor. Curr Opin Hematol 10:142-149 doi: 10.1097/00062752-200303000-00008
4. Sadler JE (1998) Biochemistry and genetics of von Willebrand factors. Annu Rev Biochem 67:395-424 doi: 10.1146/annurev.biochem.67.1.395
5. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L et al (2006) Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 4:2103-2114 doi: 10.1111/ j.1538-7836.2006.02146.x
6. Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM et al (1991) Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 30:253-269 doi: 10.1021/bi00215a036
7. Kunkel GR, Graham JB, Fowlkes DM, Lord ST (1990) Rsa I polymorphism in von Willebrand factor (VWF) at codon 789. Nucleic Acids Res 18:4961 doi: 10.1093/nar/18.16.4961-a
8. Bowen DJ, Collins PW (2003) An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood 103:941-947 doi: 10.1182/blood-2003-05-1505
9. Davies JA, Bowen DJ (2007) The association between the L1565 genotype of von Willebrand factor and susceptibility to proteolysis by ADAMTS13. Haematologica 92:240-243 doi: 10.3324/haematol.10633
10. Hassenpflug WA, Budde U, Obser T, Angerhaus D, Drewke E, Schneppenheim S et al (2006) Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13 dependent proteolysis. Blood 107:2339-2345 doi: 10.1182/ blood-2005-04-1758
11. Lacquemant C, Gaucher C, Delorme C et al (2000) Association between high von Willebrand factor levels and the Thr789Ala VWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. Kidney Int 57:1437-1443 doi: 10.1046/ j.1523-1755.2000.00988.x
12. Simon D, Bandinelli E, Roisenberg I (2003) Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type-1. Genet Mol Biol 26:397-401 doi: 10.1590/S1415-47572003000400001
13. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D (1999) Variation at the von Willebrand Factor (VWF) gene locus is associated with plasma VWF:IG levels: identification of three novel single nucleotide polymorphisms in the VWF gene promoter. Blood 93:4277-4283
14. Moore RE, Seidman DD, Smith JC, Struhl K (1992) Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York, pp 2.1.1-2.1.7
15. Ivy AC, Nelson D, Buchet G (1941) The standardization of certain factors in the cutaneous 'venostasis' bleeding time technique. J Lab Clin Med 26:1812-1822
16. Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, Mc Pherson JA (1975) A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 34:306-308
17. Graham JB, Kunkel GR, Tennyson GS, Lord ST, Fowlkes DM (1989) The Malmo polymorphism of factor IX: Establishing the genotypes by rapid analysis of DNA. Blood 73:2104-2107
18. Kogan SC, Doherty M, Gitschier J (1987) An improved method for prenatal diagnosis of genetic disease by analysis of amplified DNA sequence: application to hemophilia A. N Engl J Med 317:985-990
19. Gupta PK, Ahmad RPH, Sazawal S, Choudhry VP, Saxena R (2005) Relatively high frequency of VWD type 3 and 2 in cohort of Indian patient: The role of multimeric analysis. J Thromb Haemost 3:1321-1322 doi: 10.1111/ j.1538-7836.2005.01336.x
20. Klemm T, Mehnert AK, Siegemund A, Wiesner TD, Gelbrich G, Bluher M et al (2005) Impact of the Thr789Ala genotype of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 113:568-572 doi: 10.1055/ s-2005-872896
21. Harvey PJ, Keightley AM, Lam YM, Cameron C, Lillicrap D (2000) A single nucleotide polymorphism at nucleotide -793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. Br J Haematol 109:349-353 doi: 10.1046/j.1365-2141.2000.02000.x
22. Beranek M, Kankova K, Kolar P, Znojil V (2002) Polymorphisms in the von Willebrand factor gene are not associated with proliferative retinopathy in non-insulin-dependent diabetes mellitus. Ophthalmic Res 34:327-330 doi: 10.1159/000065604
23. Vischer UM (2006) von Willebrand factor, endothelial dysfunction and cardiovascular disease. J Thromb Haemost 4:1186-1193 doi: 10.1111/ j.1538-7836.2006.01949.x